BCMA CAR T for AL Amyloidosis After Plasmacytic Relapse of Lymphoplasmacytic Lymphoma
{{output}}
Introduction: Lambda immunoglobulin light chain (AL) amyloidosis associated with non-IgM lymphoplasmacytic lymphoma (LPL) is rare and often refractory to conventional therapies. Treatment options for relapsed disease remain limit... ...